Syncardia Systems LLC - Strategic SWOT Analysis Review
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – GlobalData’s summarization of the company’s business strategy.
SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients suffering from final stage biventricular heart failure (BHF) before receiving a successful heart transplant. The TAH-t replaces the ventricles and four heart valves of a failing heart and eliminates the symptoms and source of end-stage BHF. SynCardia also offers the Freedom portable external pneumatic drivers, which power TAH-t and facilitate the discharge of clinically stable patients from the hospital, while waiting for a matching donor heart. The company offers TAH-t through certified centers in various parts of Europe, North America and Asia-Pacific. The company operates through its subsidiary in Germany. SynCardia is headquartered in Tucson, Arizona, the US.
Syncardia Systems LLC Key Recent Developments
Jun 21,2017: Italian Boy Becomes Youngest Patient Bridged to Transplant with the SynCardia temporary Total Artificial Heart Mar 14,2017: SynCardia Names New VP of Manufacturing and Facilities
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.